Article

Metabolites Useful in Finding Preserved Ejection Fraction Heart Failure

Author(s):

Certain metabolites could be used as new biomarkers for heart failure with preserved ejection fraction.

Little is known about the mechanisms underlying heart failure with preserved ejection fraction (HFpEF). A study led by Wynn Hunter, a candidate for MD, MHSc degrees at Duke University School of Medicine looked at metabolomics profiles of patients with reduced ejection fraction, preserved ejection fraction, and normal controls.

To do that targeted, quantitative mass spectrometry-based measurements of 69 metabolites was performed on fasting plasma from 2,645 patients in the CATHGEN biorepository.

There were significant differences in the 3 groups, Hunter wrote in an abstract to be presented as at a poster session Saturday, March 14 at the American College of Cardiology meeting in San Diego, CA.

Those differences were seen in five PCA-derived factor levels after adjust for multiple comparisons at the level of 14 factors: long-chain dicarboxylacylcarnitines, long-chain acylcarnitines, ketone-related, and very long chain acylcarnitines. Mean levels of these factors were highest in the group with reduced ejection fraction, intermediate in the group with preserved ejection fraction, and lowest in the normal group.

The study suggests that these metabolites could be used as new biomarkers for HFpEF, and potentially be used to identify high-risk subtypes.

Related Videos
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
Ahmad Masri, MD, MS: Reaching New Milestones in Cardiovascular Gene Therapy Development
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
© 2024 MJH Life Sciences

All rights reserved.